MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.
home > drug information > Zoloft

Zoloft (sertraline HCl)


Company: Pfizer
Approval Status: Approved May 2002
Treatment for: Mood disorders
Areas: Obstetrics/Gynecology; Psychiatry/Psychology
Possible similar drugs: Zoloft; Zoloft

| General Information | Clinical Results | Side Effects | Mechanism of Action | Additional Information |


General Information

Other Useful Resources

Zoloft has been approved for the treatment of Premenstrual Dysphoric Mood Disorder (PMDD). It can be taken either daily or for the two weeks before a woman's period. Zoloft is also indicated for the treatment of depression, posttraumatic stress disorder, panic disorder and obsessive-compulsive disorder.

PMDD exhibits symptoms similar to those seen with major depressive disorder and other mood disorders, but is distinguishable from such disorders by its cyclical nature. The intense physical and emotion symptoms associated with PMDD are present only between ovulation and menstruation. It is estimated that three to five percent of American women suffer from PMDD.



< back to top

Clinical Results

The approval of Zoloft for the treatment of PMDD is supported by two placebo-controlled trials involving 532 women diagnosed with the disorder. Zoloft was significantly more effective in improving emotional and behavioral symptoms of PMDD than placebo, regardless if the drug was taken continously or only during the premenstrual phase of the menstrual cycle. These symptoms included feelings of being depressed, hopeless or overwhelmed, and being angry or irritable and having conflicts with others. Those who were admistered Zoloft every day also noted improvement in physical symptoms including breast tenderness, bloating and headache.



< back to top

Side Effects

Adverse events associated with the use of Zoloft may include (but are not limited to) the following:


  • Upset stomach
  • Trouble sleeping
  • Diarrhea
  • Abdominal pain
  • Dry mouth
  • Sexual dysfunction

< back to top

Mechanism of Action

Zoloft (sertraline HCl) is a selective serotonin reuptake inhibitor. Zoloft helps correct the chemical imbalance of serotonin in the brain. The effectiveness of Zoloft is presumed to be linked to its inhibition of CNS neuronal uptake of serotonin (5HT). Serotonin is a naturally occurring chemical in the brain that is involved in the transmission of messages between nerve cells.



< back to top

Additional Information

For additional information on Zoloft, please visit Zoloft.



< back to top



The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.




free web search box


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<




add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.